Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gelteq (GELS) Cash & Equivalents (2023 - 2025)

Gelteq has reported Cash & Equivalents over the past 3 years, most recently at $220724.0 for Q2 2025.

  • For Q2 2025, Cash & Equivalents rose 1265.82% year-over-year to $220724.0; the TTM value through Jun 2025 reached $220724.0, up 1265.82%, while the annual FY2025 figure was $220724.0, 1265.82% up from the prior year.
  • Cash & Equivalents for Q2 2025 was $220724.0 at Gelteq, down from $2.0 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $2.0 million in Q4 2024 and troughed at $16160.6 in Q2 2024.
  • A 3-year average of $624013.9 and a median of $243774.8 in 2023 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: tumbled 93.94% in 2024 and later surged 1265.82% in 2025.
  • Year by year, Cash & Equivalents stood at $266825.5 in 2023, then skyrocketed by 646.68% to $2.0 million in 2024, then tumbled by 88.92% to $220724.0 in 2025.
  • Business Quant data shows Cash & Equivalents for GELS at $220724.0 in Q2 2025, $2.0 million in Q4 2024, and $16160.6 in Q2 2024.